Chronic Hepatitis B Genotype C Mouse Model with Persistent Covalently Closed Circular DNA

被引:0
作者
Seo, Deok-Hwa [1 ]
Hur, Wonhee [2 ,5 ]
Won, Juhee [3 ]
Han, Ji-Won [4 ]
Yoon, Seung-Kew [4 ]
Bae, Songmee [2 ]
Kim, Kyun-Hwan [3 ]
Sung, Pil-Soo [1 ,4 ]
机构
[1] Catholic Univ Korea, Coll Med, Liver Res Ctr, Seoul 06591, South Korea
[2] Natl Inst Hlth, Ctr Emerging Virus Res, Div Chron Viral Dis, Cheongju 28159, South Korea
[3] Sungkyunkwan Univ, Sch Med, Dept Precis Med, Suwon 16419, South Korea
[4] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Div Gastroenterol & Hepatol,Dept Internal Med, Seoul 06591, South Korea
[5] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA
来源
VIRUSES-BASEL | 2024年 / 16卷 / 12期
关键词
Hepatitis B virus; genotype C; cccDNA; mouse model; chronic HBV infection; CCCDNA;
D O I
10.3390/v16121890
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Hepatitis B virus (HBV) can cause chronic infections, significantly increasing the risk of death from cirrhosis and hepatocellular carcinoma (HCC). A key player in chronic HBV infection is covalently closed circular DNA (cccDNA), a stable episomal form of viral DNA that acts as a persistent reservoir in infected hepatocytes and drives continuous viral replication. Despite the development of several animal models, few adequately replicate cccDNA formation and maintenance, limiting our understanding of its dynamics and the evaluation of potential therapeutic interventions targeting cccDNA. In this study, we aimed to develop a mouse model to investigate cccDNA formation and maintenance. We infected C57BL/6 mice with recombinant adeno-associated virus (rAAV) carrying a 1.3-overlength HBV genome (genotype C) and collected liver tissue at various time points to assess cccDNA levels and viral replication. Our results demonstrated the successful establishment of a chronic hepatitis B mouse model using rAAV-HBV1.3, which supported persistent HBV infection with sustained cccDNA expression in hepatocytes. Serum levels of HBsAg and HBeAg were elevated for up to 12 weeks, while alanine transaminase (ALT) levels remained within the normal range, indicating limited liver damage during this period. We confirmed HBV DNA expression in hepatocytes, and importantly, cccDNA was detected using qPCR after Plasmid-Safe ATP-Dependent DNase treatment, which selectively removes non-cccDNA forms. Additionally, Southern blot analysis confirmed the presence of cccDNA isolated using the Hirt extraction method. This established model provides a valuable platform for studying the long-term maintenance of cccDNA in chronic HBV infection and offers an important tool for testing novel therapeutic strategies aimed at targeting cccDNA.
引用
收藏
页数:9
相关论文
共 26 条
  • [1] Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cure
    Allweiss, Lena
    Testoni, Barbara
    Yu, Mei
    Lucifora, Julie
    Ko, Chunkyu
    Qu, Bingqian
    Luetgehetmann, Marc
    Guo, Haitao
    Urban, Stephan
    Fletcher, Simon P.
    Protzer, Ulrike
    Levrero, Massimo
    Zoulim, Fabien
    Dandri, Maura
    [J]. GUT, 2023, 72 (05) : 972 - 983
  • [2] HBV cccDNA-A Culprit and Stumbling Block for the Hepatitis B Virus Infection: Its Presence in Hepatocytes Perplexed the Possible Mission for a Functional Cure
    Bhat, Sajad Ahmad
    Kazim, Syed Naqui
    [J]. ACS OMEGA, 2022, 7 (28): : 24066 - 24081
  • [3] Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction
    Dezhbord, Mehrangiz
    Kim, Seong Ho
    Park, Soree
    Lee, Da Rae
    Kim, Nayeon
    Won, Juhee
    Lee, Ah Ram
    Kim, Dong-Sik
    Kim, Kyun-Hwan
    [J]. CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 (03) : 539 - 560
  • [4] In Vivo Mouse Models for Hepatitis B Virus Infection and Their Application
    Du, Yanqin
    Broering, Ruth
    Li, Xiaoran
    Zhang, Xiaoyong
    Liu, Jia
    Yang, Dongliang
    Lu, Mengji
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [5] Hepatitis B Virus Targets Lipid Transport Pathways to Infect Hepatocytes
    Esser, Knud
    Cheng, Xiaoming
    Wettengel, Jochen M.
    Lucifora, Julie
    Hansen-Palmus, Lea
    Austen, Katharina
    Suarez, Armando A. Roca
    Heintz, Sarah
    Testoni, Barbara
    Nebioglu, Firat
    Pham, Minh Tu
    Yang, Shangqing
    Zernecke, Alma
    Wohlleber, Dirk
    Ringelhan, Marc
    Broxtermann, Mathias
    Hartmann, Daniel
    Hueser, Norbert
    Mergner, Julia
    Pichlmair, Andreas
    Thasler, Wolfgang E.
    Heikenwalder, Mathias
    Gasteiger, Georg
    Blutke, Andreas
    Walch, Axel
    Knolle, Percy A.
    Bartenschlager, Ralf
    Protzer, Ulrike
    [J]. CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2023, 16 (02): : 201 - 221
  • [6] Functional cure of hepatitis B requires silencing covalently closed circular and integrated hepatitis B virus DNA
    Ghany, Marc G.
    Lok, Anna S.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2022, 132 (18)
  • [7] Mouse models for hepatitis B virus research
    Hwang J.-R.
    Park S.-G.
    [J]. Laboratory Animal Research, 2018, 34 (3) : 85 - 91
  • [8] An Evidence-based Practical Guide to Vaccination for Hepatitis B Virus
    Jacobson, Ira M.
    Brown, Robert S., Jr.
    McMahon, Brian J.
    Perrillo, Robert P.
    Gish, Robert
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2022, 56 (06) : 478 - 492
  • [9] Targeting hepatitis B virus cccDNA levels: Recent progress in seeking small molecule drug candidates
    Jin, Yu
    Wang, Shuo
    Xu, Shujing
    Zhao, Shujie
    Xu, Xiangrui
    Poongavanam, Vasanthanathan
    Menendez-Arias, Luis
    Zhan, Peng
    Liu, Xinyong
    [J]. DRUG DISCOVERY TODAY, 2023, 28 (07)
  • [10] Intramolecular recombination enables the formation of hepatitis B virus (HBV) cccDNA in mice after HBV genome transfer using recombinant AAV vectors
    Ko, Chunkyu
    Su, Jinpeng
    Festag, Julia
    Bester, Romina
    Kosinska, Anna D.
    Protzer, Ulrike
    [J]. ANTIVIRAL RESEARCH, 2021, 194